NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$246.3(1.2%)
Market Cap$31.7B
(19.0%)
Industry median - (122.4%)
5Y Historical average - (72.8%)
(25.8%)
Industry median - (129.8%)
5Y Historical average - (78.4%)
(2,269.0%)
Industry median - (52.2%)
5Y Historical average - (163.4%)
(6.7%)
Industry median - (51.2%)
5Y Historical average - (26.1%)
ALNY Capital Allocation Rating
Crunching data... Almost there!
ALNY Capital Allocation metrics
Crunching data... Almost there!
Competing with ALNY Capital Allocation
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Alnylam Pharmaceuticals, Inc. (ALNY) ROIC (Return on Invested Capital)?
The Alnylam Pharmaceuticals, Inc. (ALNY) ROIC is (19.0%), compared to the industry median of ((122.4%)) and the 5-year historical average of (72.8%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) ROIC minus WACC (Weighted Average Cost of Capital)?
The Alnylam Pharmaceuticals, Inc. (ALNY) ROIC minus WACC is (25.8%), compared to the industry median of ((129.8%)) and the 5-year historical average of (78.4%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) ROE (Return on Equity)?
The Alnylam Pharmaceuticals, Inc. (ALNY) ROE is (2,269.0%), compared to the industry median of ((52.2%)) and the 5-year historical average of (163.4%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) ROCE (Return on Capital Employed)?
The Alnylam Pharmaceuticals, Inc. (ALNY) ROCE is (6.7%), compared to the industry median of ((51.2%)) and the 5-year historical average of (26.1%).